ON MOTION FOR RECONSIDERATION
HARRELL, J.
Appellees moved timely for reconsideration of the Court’s opinion filed on 26 February 2013. Although re-arguing in the [504]*504motion, for the most part, the doctrinal and other purely legal issues decided by this Court in that opinion,1 Appellees brought to our attention also certain particularized errors regarding our categorization and disposition of the claims of certain Appellees among the 466 plaintiffs. Although we decline to reconsider our opinion based on Appellees’ substantive legal arguments, the motion to reconsider is granted in part for the limited purpose of explaining or remedying the application of the law to the individual Appellees described below.
With respect to the trial court judgments for emotional distress for fear of cancer, Appellees contend first that the judgment entered in favor of Gloria Quinan should be affirmed, rather than reversed and remanded for a new trial. We disagree. In light of our analysis in Albright, the trial court’s instructions to the jury concerning the requirements for actual exposure and objective, reasonable fear of developing disease were incorrect. For example, the instructions did not require the jury to consider scientific or medical evidence in determining whether the fear of contracting cancer was objectively reasonable, see op. at 365, 71 A.3d at 68 (noting that “there is credible scientific evidence to suggest levels of exposure to benzene and MTBE at which a fear of developing cancer becomes objectively reasonable”); Faya v. Almaraz, 329 Md. 435, 455, 620 A.2d 327, 337 (1993) (determining that fear of contracting HIV was objectively reasonable only within a certain window of time based on “current credible evidence of a 95% certainty that one will test positive for the AIDS [505]*505virus, if at all, within six months after exposure to it”), but rather permitted the jury to consider “[rjesearch of any kind, discussions with other persons including other [Appellees], consultations with health care providers, conversations with agents and employees of the Defendant [Exxon] and/or the Maryland Department of the Environment” in determining the reasonableness of Appellees’ fears. Thus, by permitting such lay testimony to be considered by the jury in determining the objective reasonableness, rather than only the genuine nature, of the Appellees’ fears, the instructions did not cover fairly the applicable law as we determined it to be. Although we opined that Ms. Quinan demonstrated an objectively reasonable fear, under the circumstances of this case, by virtue of her well-test results at or exceeding the actionable levels of exposure to MTBE, based on “credible scientific evidence,” at which a fear of developing cancer becomes objectively reasonable, op. at 365-66, 71 A.3d at 67-68, our extended discussion of Ms. Quinan’s claim shows that her claim should be presented to a properly-instructed jury for determination of damages. See op. at 375-76, 71 A.3d at 73-74.
Second, the motion argues that the fear of cancer damages claims of three additional Appellees — Amy Gumina, Rochelle Roth, and Steven Roth — should be treated similarly to how we treated Ms. Quinan’s claim because these Appellees presented expert testimony linking causally an alleged physical injury to the Exxon leak. Exxon concedes, in its answer to the motion for reconsideration, that Amy Gumina is entitled to a new trial with respect to emotional distress for fear of cancer. We agree and modify our opinion and mandate to reflect remand of her claim for a new trial. Upon revisiting the evidence admitted on behalf of Rochelle and Steven Roth, however, we determine that the evidence relating to a fear of contracting cancer was insufficient as a matter of law and does not demonstrate a physical injury capable of objective determination.2 Specifically, although Dr. Malik testified that Ste[506]*506ven Roth suffered from anxiety resulting from the Exxon leak, Mr. Roth did not present sufficient evidence linking his distress and alleged physical manifestations to his concern for his future health, nor did he provide sufficiently descriptive testimony to render his anxiety capable of objective determination. Rather, he testified primarily as to his concern for the loss of property value and his preexisting health conditions. Similarly, the testimony presented by Rochelle Roth is insufficient to support an award for emotional distress for fear of contracting cancer. Much of Mrs. Roth’s testimony contains references to skin problems that she developed that were not linked causally by a medical expert to the Exxon release, and thus, like Ms. Quinan’s rash discussed in Albright, may not support an award of emotional distress damages on this record. See op. at 372 n. 69, 71 A.3d at 72 n. 69. Although Mrs. Roth’s testimony focused primarily on the financial impacts of the leak and her skin problems, to the extent that she testified regarding her health concerns, her testimony consisted primarily of conclusory statements not reaching the level of detail regarding the extent, duration, or frequency of physical impact as the testimony presented by Ms. Quinan. Additionally, although Dr. Malik testified regarding a causal link and a diagnosis for Mrs. Roth, as we noted previously with regard to his testimony concerning Ms. Quinan, it “contained conclusory statements which otherwise might be insufficient to establish physical injury.” Op. at 376, 71 A.3d at 74. Thus, we conclude that the testimony offered in support of the Roths’ claims for emotional distress damages for fear of cancer was insufficient as a matter of law and the earlier disposition of their claims in our opinion remains appropriate.
In considering those Appellees to whom Exxon concedes more clearly now that it was liable for some category of [507]*507compensatory damages, we omitted erroneously3 the names of Christopher Easton, Monique Easton, Mark Kirkwood, and Nancy Pugliese Kirkwood as individuals entitled to a new trial on the claim of diminution in value of real property. These Appellees’ names were not included on Exxon’s preliminary list of Appellees to whom liability was admitted, but liability was conceded to these Appellees during cross-examination and closing argument by Exxon’s counsel at trial. Exxon concedes, and we agree, that these individuals are entitled to a new trial on their claims of diminution in value of real property. Additionally, this Court listed incorrectly in its opinion the properties of Ann Fuller, Stanley Fuller, Donald Nemer, Kelli Nemer, Mary Kathryn Proefrock, Scott Proefrock, and Hans Wilhelmsen (property located at 13729 Jarrettsville Pike) as “non-detect” properties. See op. at 406-07 n. 92, 71 A.3d at 93 n. 92. Each property’s well water tested positive for gasoline constituents,4 however, and to be consistent with the opinion in Albright, the individuals listed are entitled to a new trial on diminution in value of real property. See generally op. at 363-64 n. 60, 367 n. 65, 71 A.3d at 67 n. 60, 69 n. 65 (noting that, where conflicting evidence regarding groundwater flow and property contamination was presented, the evidence must be considered in the light most favorable to the Appellees).
Free access — add to your briefcase to read the full text and ask questions with AI
ON MOTION FOR RECONSIDERATION
HARRELL, J.
Appellees moved timely for reconsideration of the Court’s opinion filed on 26 February 2013. Although re-arguing in the [504]*504motion, for the most part, the doctrinal and other purely legal issues decided by this Court in that opinion,1 Appellees brought to our attention also certain particularized errors regarding our categorization and disposition of the claims of certain Appellees among the 466 plaintiffs. Although we decline to reconsider our opinion based on Appellees’ substantive legal arguments, the motion to reconsider is granted in part for the limited purpose of explaining or remedying the application of the law to the individual Appellees described below.
With respect to the trial court judgments for emotional distress for fear of cancer, Appellees contend first that the judgment entered in favor of Gloria Quinan should be affirmed, rather than reversed and remanded for a new trial. We disagree. In light of our analysis in Albright, the trial court’s instructions to the jury concerning the requirements for actual exposure and objective, reasonable fear of developing disease were incorrect. For example, the instructions did not require the jury to consider scientific or medical evidence in determining whether the fear of contracting cancer was objectively reasonable, see op. at 365, 71 A.3d at 68 (noting that “there is credible scientific evidence to suggest levels of exposure to benzene and MTBE at which a fear of developing cancer becomes objectively reasonable”); Faya v. Almaraz, 329 Md. 435, 455, 620 A.2d 327, 337 (1993) (determining that fear of contracting HIV was objectively reasonable only within a certain window of time based on “current credible evidence of a 95% certainty that one will test positive for the AIDS [505]*505virus, if at all, within six months after exposure to it”), but rather permitted the jury to consider “[rjesearch of any kind, discussions with other persons including other [Appellees], consultations with health care providers, conversations with agents and employees of the Defendant [Exxon] and/or the Maryland Department of the Environment” in determining the reasonableness of Appellees’ fears. Thus, by permitting such lay testimony to be considered by the jury in determining the objective reasonableness, rather than only the genuine nature, of the Appellees’ fears, the instructions did not cover fairly the applicable law as we determined it to be. Although we opined that Ms. Quinan demonstrated an objectively reasonable fear, under the circumstances of this case, by virtue of her well-test results at or exceeding the actionable levels of exposure to MTBE, based on “credible scientific evidence,” at which a fear of developing cancer becomes objectively reasonable, op. at 365-66, 71 A.3d at 67-68, our extended discussion of Ms. Quinan’s claim shows that her claim should be presented to a properly-instructed jury for determination of damages. See op. at 375-76, 71 A.3d at 73-74.
Second, the motion argues that the fear of cancer damages claims of three additional Appellees — Amy Gumina, Rochelle Roth, and Steven Roth — should be treated similarly to how we treated Ms. Quinan’s claim because these Appellees presented expert testimony linking causally an alleged physical injury to the Exxon leak. Exxon concedes, in its answer to the motion for reconsideration, that Amy Gumina is entitled to a new trial with respect to emotional distress for fear of cancer. We agree and modify our opinion and mandate to reflect remand of her claim for a new trial. Upon revisiting the evidence admitted on behalf of Rochelle and Steven Roth, however, we determine that the evidence relating to a fear of contracting cancer was insufficient as a matter of law and does not demonstrate a physical injury capable of objective determination.2 Specifically, although Dr. Malik testified that Ste[506]*506ven Roth suffered from anxiety resulting from the Exxon leak, Mr. Roth did not present sufficient evidence linking his distress and alleged physical manifestations to his concern for his future health, nor did he provide sufficiently descriptive testimony to render his anxiety capable of objective determination. Rather, he testified primarily as to his concern for the loss of property value and his preexisting health conditions. Similarly, the testimony presented by Rochelle Roth is insufficient to support an award for emotional distress for fear of contracting cancer. Much of Mrs. Roth’s testimony contains references to skin problems that she developed that were not linked causally by a medical expert to the Exxon release, and thus, like Ms. Quinan’s rash discussed in Albright, may not support an award of emotional distress damages on this record. See op. at 372 n. 69, 71 A.3d at 72 n. 69. Although Mrs. Roth’s testimony focused primarily on the financial impacts of the leak and her skin problems, to the extent that she testified regarding her health concerns, her testimony consisted primarily of conclusory statements not reaching the level of detail regarding the extent, duration, or frequency of physical impact as the testimony presented by Ms. Quinan. Additionally, although Dr. Malik testified regarding a causal link and a diagnosis for Mrs. Roth, as we noted previously with regard to his testimony concerning Ms. Quinan, it “contained conclusory statements which otherwise might be insufficient to establish physical injury.” Op. at 376, 71 A.3d at 74. Thus, we conclude that the testimony offered in support of the Roths’ claims for emotional distress damages for fear of cancer was insufficient as a matter of law and the earlier disposition of their claims in our opinion remains appropriate.
In considering those Appellees to whom Exxon concedes more clearly now that it was liable for some category of [507]*507compensatory damages, we omitted erroneously3 the names of Christopher Easton, Monique Easton, Mark Kirkwood, and Nancy Pugliese Kirkwood as individuals entitled to a new trial on the claim of diminution in value of real property. These Appellees’ names were not included on Exxon’s preliminary list of Appellees to whom liability was admitted, but liability was conceded to these Appellees during cross-examination and closing argument by Exxon’s counsel at trial. Exxon concedes, and we agree, that these individuals are entitled to a new trial on their claims of diminution in value of real property. Additionally, this Court listed incorrectly in its opinion the properties of Ann Fuller, Stanley Fuller, Donald Nemer, Kelli Nemer, Mary Kathryn Proefrock, Scott Proefrock, and Hans Wilhelmsen (property located at 13729 Jarrettsville Pike) as “non-detect” properties. See op. at 406-07 n. 92, 71 A.3d at 93 n. 92. Each property’s well water tested positive for gasoline constituents,4 however, and to be consistent with the opinion in Albright, the individuals listed are entitled to a new trial on diminution in value of real property. See generally op. at 363-64 n. 60, 367 n. 65, 71 A.3d at 67 n. 60, 69 n. 65 (noting that, where conflicting evidence regarding groundwater flow and property contamination was presented, the evidence must be considered in the light most favorable to the Appellees).
Lastly, Appellees contend that Exxon admitted, in closing argument at trial, liability for loss of use and enjoyment damages in specified amounts to a number of Appellee families (in addition to and irrespective of any damages awarded for diminution in value of real property), and thus judg[508]*508ment should be entered by us in favor of those Appellees.5 Upon revisiting Exxon’s statements made, during closing argument and considering them in the broader context of the full trial, and notwithstanding the failure of the parties to bring the alleged concession to this Court’s attention during the appeal, we disagree with Appellees’ assertion. Exxon objected repeatedly at trial to Appellees’ request for, and the trial court’s allowance to reach the jury, of duplicative damages claims for both loss of use and enjoyment and diminution in value of real property. Although Exxon conceded that it owed some category of compensatory damages to the Appellees listed, Exxon preserved specifically its objection to the award of loss of use and enjoyment damages (in addition to diminution in value) as to the preliminary list of Appellees to whom liability was conceded, filed a motion for judgment on this [509]*509specific issue, and reiterated again its objection before the trial judge on 15 June 2011, two days before the alleged concessions were made. Although Appellees note correctly that admissions made by counsel in open court are binding generally upon the party represented, see, e.g., Secor v. Brown, 221 Md. 119, 123, 156 A.2d 225, 227 (1959) (“[TJhere is a prima facie presumption that an attorney has authority to bind his client by his actions relating to the conduct of litigation.”), that rule is not applied properly here, where Exxon’s counsel noted repeatedly an objection to the trial court on what was ruled later by the trial judge to be a question of law, and was obliged in the face of that ruling thereafter to argue to the jury in a manner consistent with the trial court’s ruling and instructions. Reversal of the loss of use and enjoyment awards was therefore appropriate.6
There is one additional matter not raised in Albright by the parties, but which the Court, in good conscience, must raise on its initiative. In view of the Court’s decision in Exxon Mobil Corp. v. Ford, 433 Md. 493, 71 A.3d 144 (2013), in ruling on Exxon’s amended request for bond premium costs, to revise the Court’s mandate to provide that the parties there shall bear their own costs, parity of reasoning compels us to revise the mandate in Albright to direct that, rather than Respondents there bearing all costs on a pro rata basis, the parties shall bear their own costs.
As to all other claims and issues, the motion for reconsideration is denied.